{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:37:47Z","timestamp":1777689467873,"version":"3.51.4"},"reference-count":17,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"skintegrity.ch","award":["Skintegrity"],"award-info":[{"award-number":["Skintegrity"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2024,5,4]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Clinical observation suggests that vascular activation and autoimmunity precede remodelling of the extracellular matrix (ECM) in systemic sclerosis (SSc). We challenge this paradigm by hypothesising that ECM biomarkers are already disturbed in patients with very early SSc (veSSc) when fibrosis is not yet clinically detectable.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>42 patients with veSSc, defined as the presence of Raynaud\u2019s phenomenon and at least one of puffy fingers, positive antinuclear antibodies or pathological nailfold capillaroscopy, not meeting the 2013 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for SSc, were compared with healthy controls (HCs, n=29). ECM degradation (BGM, C3M, C4M and C6M) and ECM formation biomarkers (PRO-C3, PRO-C4 and PRO-C5) were measured in serum using ELISAs. A cross-sectional analysis at baseline and a longitudinal analysis was performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with HC, veSSc patients showed a strongly dysregulated turnover of type III and IV collagens (higher C3M, C4M, both p&lt;0.0001\u2009and PRO-C3, p=0.004, lower turnover ratios PRO-C3\/C3M and PRO-C4\/C4M, both p&lt;0.0001). The biglycan degradation biomarker BGM was higher in veSSc than in HC (p=0.006), whereas the degradation biomarker for type VI collagen, C6M, was lower (p=0.002). In an ROC analysis, biomarkers of type III and IV collagen excellently distinguished between veSSc and HC: C3M, AUC=0.95, p&lt;0.0001; C4M, AUC=0.97, p&lt;0.0001; turnover ratios PRO-C3\/C3M, AUC=0.80, p&lt;0.0001; PRO-C4\/C4M, AUC=0.97; p&lt;0.0001.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These findings indicate ECM remodelling as a very early phenomenon of SSc occurring in parallel with microvascular and autoimmune changes. Biomarkers of type III and IV collagens distinguished between veSSc patients and HC, indicating them as potential biomarkers for the detection of veSSc.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003306","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T13:31:18Z","timestamp":1716903078000},"page":"e003306","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Dysregulation of circulating collagen turnover markers in very early systemic sclerosis"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9819-7574","authenticated-orcid":false,"given":"Rucsandra","family":"Dobrota","sequence":"first","affiliation":[{"name":"Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana","family":"Jordan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernille","family":"Juhl","sequence":"additional","affiliation":[{"name":"Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Immunoscience, Nordic Bioscience, Herlev, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Del Papa","sequence":"additional","affiliation":[{"name":"Scleroderma Clinic, Department of Rheumatology, ASST G. Pini-CTO, Universita degli Studi di Milano, Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Maurer","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland"},{"name":"Department of Rheumatology and Immunology, Inselspital University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Becker","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8627-8817","authenticated-orcid":false,"given":"Carina","family":"Mihai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-C","family":"Bay-Jensen","sequence":"additional","affiliation":[{"name":"Department of Immunoscience, Nordic Bioscience, Herlev, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten Asser","family":"Karsdal","sequence":"additional","affiliation":[{"name":"Department of Immunoscience, Nordic Bioscience, Herlev, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Sofie","family":"Siebuhr","sequence":"additional","affiliation":[{"name":"Department of Immunoscience, Nordic Bioscience, Herlev, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0546-8310","authenticated-orcid":false,"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"2025090312261562000_10.2.e003306.1","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2025090312261562000_10.2.e003306.2","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2019.101428","article-title":"Very early systemic sclerosis","volume":"33","author":"Bellando-Randone","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025090312261562000_10.2.e003306.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.106302"},{"key":"2025090312261562000_10.2.e003306.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203716"},{"key":"2025090312261562000_10.2.e003306.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.136929"},{"key":"2025090312261562000_10.2.e003306.6","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190976"},{"key":"2025090312261562000_10.2.e003306.7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq374"},{"key":"2025090312261562000_10.2.e003306.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.37988"},{"key":"2025090312261562000_10.2.e003306.9","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/S2665-9913(20)30385-4","article-title":"Circulating collagen Neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a Multicentre cohort study","volume":"3","author":"Dobrota","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2025090312261562000_10.2.e003306.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204424"},{"key":"2025090312261562000_10.2.e003306.11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.142489"},{"key":"2025090312261562000_10.2.e003306.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.062901"},{"key":"2025090312261562000_10.2.e003306.13","first-page":"303","article-title":"The Neo-EPITOPE specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters","volume":"5","author":"Nielsen","year":"2013","journal-title":"Am J Transl Res"},{"key":"2025090312261562000_10.2.e003306.14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1872-034X.2011.00946.x","article-title":"Enzyme-linked immunosorbent serum assay specific for the 7S domain of collagen type IV (P4Np 7S): A marker related to the extracellular matrix remodeling during liver Fibrogenesis","volume":"42","author":"Leeming","year":"2012","journal-title":"Hepatol Res"},{"key":"2025090312261562000_10.2.e003306.15","doi-asserted-by":"publisher","DOI":"10.3109\/1354750X.2011.584131"},{"key":"2025090312261562000_10.2.e003306.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2237-8"},{"key":"2025090312261562000_10.2.e003306.17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/1354750X.2018.1548032","article-title":"Citrullinated Vimentin and Biglycan protein fingerprints as candidate serological biomarkers for disease activity in systemic sclerosis: A pilot study","volume":"24","author":"Siebuhr","year":"2019","journal-title":"Biomarkers"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:26:24Z","timestamp":1756927584000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,5,28]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/rmdopen-2023-003306"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003306","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]}}}